Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in Man, Phase I Study Investigating the Safety and Tolerability of EP395 in Healthy Volunteers

NCT04819854 is registered in ClinicalTrials.gov with EpiEndo Pharmaceuticals as lead sponsor.

NCT NCT04819854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04819854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in Man, Phase I Study Investigating the Safety and Tolerability of EP395 in Healthy Volunteers
Lead sponsor
EpiEndo Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
April 5, 2021
Completion date
March 22, 2022
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult all